Remove Biotech Remove Capital Remove Globalization Remove Market Intelligence
article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.

Biotech 96
article thumbnail

Venture Capital Trends and Outlook for 2024

Alpha Sense BI

Heading into the second half of 2024, venture capital investors remain cautious as they acknowledge persistent challenging dynamics in the landscape. While dry powder reserves have reached record highs, investors are wary about deploying capital with certain recent macroeconomic factors still fresh in mind.

Capital 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Vaccine Development: What to Expect in 2023

Alpha Sense BI

Over the last three years, the COVID-19 pandemic brought new energy to manufacturing vaccines for a myriad of global diseases and health conditions. Using the AlphaSense platform, we dug deep into new drug research and development areas that will likely shape the 2023 vaccine market. a potential cure for skin cancer.

Biotech 96
article thumbnail

Technology Industry Trends and Outlook in 2024

Alpha Sense BI

On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. In fact, projections for the global spatial computing market are valued at $269.8 In any case, this technology is one to watch—the global computing market is set to grow at a CAGR of 28.8%

article thumbnail

Key Takeaways from J.P. Morgan’s 42nd Annual Healthcare Conference?

Alpha Sense BI

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.

Biotech 59
article thumbnail

M&A in Healthcare: 2024 Outlook

Alpha Sense BI

According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs.

article thumbnail

Top Expert Network Companies in 2023 (Buyer’s Guide)

Alpha Sense BI

The Value: AlphaSense is an AI-powered search engine for market intelligence. And with Stream in AlphaSense, users can leverage expert perspectives against insights derived from our extensive and ever-growing universe of content, gaining a 360 view on any market, industry, or trend.